Research
Hormonal
Targeting specific neural circuits in the brainstem and hypothalamus using peptide-based pharmacotherapies (e.g., GLP-1 mimics) is an effective strategy for inducing weight loss and treating obesity.
Consult a healthcare provider about GLP-1 based treatments if lifestyle changes alone are insufficient. These medications work by targeting brain circuits to reduce appetite and increase satiety, offering a biologically targeted approach to weight loss.
StrongSupportsHIGH confidence
Emerging pharmacotherapies that mimic gut peptides, such as glucagon-like peptide-1 (GLP-1), have shown that targeting specific neurons in the brainstem and hypothalamus is an effective strategy for inducing weight loss and lowering the risk of obesity-associated comorbidities.
Why this rating
Based on the summary of emerging pharmacotherapies and their demonstrated effectiveness.
Source
Brain control of energy homeostasis: Implications for anti-obesity pharmacotherapy
Valdemar Brimnes Ingemann Johansen et al. · Cell · 2025
narrative_reviewCited 34×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →